...
首页> 外文期刊>Electrochimica Acta >Electrochemiluminescence bioassay for thrombin based on dynamic assembly of aptamer, thrombin and N-(aminobutyl)-N-(ethylisoluminol) functionalized gold nanoparticles
【24h】

Electrochemiluminescence bioassay for thrombin based on dynamic assembly of aptamer, thrombin and N-(aminobutyl)-N-(ethylisoluminol) functionalized gold nanoparticles

机译:基于适体,凝血酶和N-(氨基丁基)-N-(乙基异鲁米诺)官能化金纳米粒子动态组装的凝血酶电化学发光生物测定

获取原文
获取原文并翻译 | 示例
           

摘要

An electrochemiluminescence (ECL) bioassay was developed for the sensitive and selective detection of thrombin, based on dynamic interaction of aptamer, thrombin and N-(aminobutyl)-N-(ethylisoluminol) (ABEI) functionalized gold nanoparticles (ABEI-AuNPs). Gold nanoparticles by citrate reduction (AuNPs) were firstly assembled onto a gold electrode through 1, 3-propanedithiol, which was further connected with thiolated DNA capture probe. Then biotinylated DNA aptamer probe was assembled onto the modified electrode through the hybridization between capture probe and aptamer probe. After adding target thrombin, aptamer could bind tightly to target molecules to form a tertiary target-aptamer complex with a binding constant greater than DNA duplex, leading to partial extrication of biotinylated DNA aptamer probe from the surface of electrode. Finally, the ABEI-AuNPs coated with streptavidin (SA) were connected with the biotinylated DNA aptamer probe left after specific binding with thrombin to form the aptamer-ABEI-AuNPs complex on the electrode. When a double-step potential was applied to the electrode, an ECL signal was generated and recorded. The decrease of ECL signal was in proportion to the concentration of thrombin over the range of 1.0 × 10~(-12)-1.0 × 10~(-9) M with a detection limit of 3.8 × 10~(-13) M. The proposed bioassay for the determination of thrombin is sensitive, specific, simple and fast. Finally, being challenged in real blood sample, the proposed bioassay was confirmed to be a good prospect for the detection of thrombin. This work provides a new way to design aptamer-based protocols for the determination of biologically important substances.
机译:基于适体,凝血酶和N-(氨基丁基)-N-(乙基异鲁米诺)(ABEI)功能化的金纳米粒子(ABEI-AuNPs)的动态相互作用,开发了一种电化学发光(ECL)生物测定法,用于凝血酶的灵敏和选择性检测。首先将柠檬酸盐还原的金纳米颗粒(AuNPs)通过1,3-丙二酚组装到金电极上,然后再与硫醇化DNA捕获探针连接。然后通过捕获探针和适体探针之间的杂交,将生物素化的DNA适体探针组装到修饰的电极上。加入目标凝血酶后,适体可与目标分子紧密结合,形成第三级目标-适体复合物,其结合常数大于DNA双链体,导致生物素化的DNA适体探针从电极表面部分脱落。最后,将涂有链霉抗生物素蛋白(SA)的ABEI-AuNPs与凝血酶特异性结合后与剩下的生物素化DNA适体探针连接,在电极上形成适体-ABEI-AuNPs复合物。当向电极施加两步电位时,会产生并记录ECL信号。 ECL信号的下降与凝血酶浓度在1.0×10〜(-12)-1.0×10〜(-9)M范围内成正比,检出限为3.8×10〜(-13)M.所提出的用于测定凝血酶的生物测定方法灵敏,特异,简单且快速。最终,在真实血液样本中受到挑战,所提出的生物测定方法被证实是检测凝血酶的良好前景。这项工作提供了一种新方法,可以设计用于确定生物学上重要物质的基于适体的方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号